article thumbnail

Infectious Disease Diagnostics Research Revolution 2024: New Report Analyzes OTC and DTC Trends and Strategies Through 2027 – ResearchAndMarkets.com

Digital Health Global

The Relationship to TeleHealth 5.3.7 ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Mesa Biotech (Thermo Fisher) 7.42 The research provides an in-depth look at the current and future market participants driving growth in this sector. Central Lab 4.3.4 Physician Office Lab’s 4.3.4.1 The Problem with POLS 4.3.5

BioTech 88
article thumbnail

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

This activity sent pharma and biotech companies scrambling to hire DE&I officers and related patient advocacy, engagement, and experience personnel as they came to terms with this foreign notion of actually collaborating with real, live patients. She is currently contracted by Parexel as their first Patient Ambassador.

BioTech 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

Here’s one of many looks into the issue , in which I’m quoted on scenarios for Gilead’s possible pricing strategies for remdesivir. In today’s pharma/biotech market, the “specialty” label is given to many therapies: for products addressing rare diseases, risk-management, and above all, high cost drugs.

BioTech 191
article thumbnail

Prescription Drugs in the Pandemic, Year 2: Pricing Rx and Going Direct-to-Consumer

Health Populi

The macro-strategy for Optum is that, in their mission-words, “health care should be equally available to everyone, when and how they want it. Integrating with the telehealth service Care on the Optum Store. There is one health care public policy issue that unites U.S.

article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Streamlining Due Diligence with AI: AI technologies will likely be crucial in conducting efficient and thorough due diligence, examining potential M&A targets in the biotech industry for their scientific innovation, financial stability, and market compatibility. Dave Latshaw, CEO at BioPhy 1.

Health IT 105
article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. Healthtech in the fast lane: What is fueling investor excitement?